Vène Elise, Jarnouen Kathleen, Ribault Catherine, Vlach Manuel, Verres Yann, Bourgeois Mickaël, Lepareur Nicolas, Cammas-Marion Sandrine, Loyer Pascal
Institut NUMECAN (Nutrition Metabolisms and Cancer), Inserm, UMR-S 1241, INRAE UMR-A 1341, Univ Rennes, F-35000 Rennes, France.
Pôle Pharmacie, Service Hospitalo-Universitaire de Pharmacie, CHU Rennes, F-35033 Rennes, France.
Pharmaceutics. 2022 Apr 6;14(4):804. doi: 10.3390/pharmaceutics14040804.
In order to identify the peptides, selected from the literature, that exhibit the strongest tropism towards human hepatoma cells, cell uptake assays were performed using biotinylated synthetic peptides bound to fluorescent streptavidin or engrafted onto nanoparticles (NPs), prepared from biotin-poly(ethylene glycol)--poly(benzyl malate) (Biot-PEG--PMLABe) via streptavidin bridging. Two peptides, derived from the circumsporozoite protein of - (CPB) and George Baker (GB) Virus A (GBVA10-9), strongly enhanced the endocytosis of both streptavidin conjugates and NPs in hepatoma cells, compared to primary human hepatocytes and non-hepatic cells. Unexpectedly, the uptake of CPB- and GBVA10-9 functionalized PEG--PMLABe-based NPs by hepatoma cells involved, at least in part, the peptide binding to apolipoproteins, which would promote NP's interactions with cell membrane receptors of HDL particles. In addition, CPB and GBVA10-9 peptide-streptavidin conjugates favored the uptake by hepatoma cells over that of the human macrophages, known to strongly internalize nanoparticles by phagocytosis. These two peptides are promising candidate ligands for targeting hepatocellular carcinomas.
为了鉴定从文献中筛选出的对人肝癌细胞具有最强嗜性的肽段,使用与荧光链霉亲和素结合或嫁接到纳米颗粒(NP)上的生物素化合成肽进行细胞摄取试验,所述纳米颗粒由生物素 - 聚(乙二醇) - 聚(苄基苹果酸)(Biot-PEG - PMLABe)通过链霉亲和素桥接制备。与原代人肝细胞和非肝细胞相比,源自疟原虫环子孢子蛋白(CPB)和乔治·贝克病毒A(GBVA10-9)的两种肽段能显著增强肝癌细胞中链霉亲和素偶联物和纳米颗粒的内吞作用。出乎意料的是,肝癌细胞对CPB和GBVA10-9功能化的基于PEG - PMLABe的纳米颗粒的摄取至少部分涉及肽段与载脂蛋白的结合,这将促进纳米颗粒与高密度脂蛋白颗粒细胞膜受体的相互作用。此外,CPB和GBVA10-9肽 - 链霉亲和素偶联物相比于已知通过吞噬作用强烈内化纳米颗粒的人巨噬细胞,更有利于肝癌细胞的摄取。这两种肽段有望成为靶向肝细胞癌的候选配体。